Abstract. Gastric cancer is the fifth most common cancer worldwide and Hippo-Yap is the novel signaling pathway which plays an important role in gastric cancer tumor development and progression. However, little insight is available to date regarding the specific role of Yes-associated protein (Yap) in gastric cancer. In the present study, we identified the mechanism through which Yap sustains gastric cancer viability and migration. Yap was greatly upregulated in gastric cancer cells and its expression promoted cellular migration and survival. Functional studies found that knockdown of Yap reduced the mitophagy activity, which subsequently caused mitochondrial apoptosis and cellular oxidative stress. The latter impaired adhesive protein expression, alleviated F-actin expression, blunted lamellipodium formation, leading to inhibition of cancer cell motility. Mechanistically, Yap preserved Sirtuin 1 (SIRT1) activity which manipulated mitofusin 2 (Mfn2) expression and subsequent mitophagy. Loss of Yap reduced SIRT1 expression and inhibited Mfn2-mediated mitophagy. Collectively, our results identified Hippo-Yap as a tumor promoter in gastric cancer that was mediated via activation of the SIRT1/Mfn2/mitophagy axis, with potential applications to gastric cancer therapy involving cancer survival and migration.
Introduction
Gastric cancers continue to pose a significant burden of morbidity and mortality globally (1) . It is estimated that gastric cancer is the fifth most common cancer worldwide, and the third leading cause of cancer-related death (2) . While important advances have been made in the early detection and treatment of gastric cancers, the majority of patients continue to present with clinical evidence of regional or distant disease (3) . While treatment for gastric cancers has traditionally involved combinations of aggressive surgical resection, chemotherapy, and radiotherapy, the percentage of patients achieving 5-year survival remains under 20% (4) . Moreover, the detection rate of early gastric cancers is low due to the lack of specific symptoms of early gastric cancer, and therefore, most patients (>70%) develop advanced-stage disease (5) . Some patients even lose the opportunity to undergo surgical resection. Metastatic potential may also exist in advanced gastric cancer, thus the overall prognosis is poor. Thereby, due to the intractable nature of these diseases, it is not surprising that attention has turned towards the mechanisms underlying cancer cell survival and migration.
Mitophagy, is an essential housekeeping process that is required to maintain tumor homeostasis. Studies suggest that mitophagy is important for eliminating impaired mitochondria both under baseline conditions and in response to stress. Mitophagy activation may reduce mitochondrial oxidative stress injury, alleviate mitochondrial calcium overload, block mitochondrial pro-apoptotic factor leakage and promote cellular ATP generation (6) (7) (8) . These data hint that mitophagy is vital for cellular homeostasis. However, research has linked impaired mitophagy to cancer suppression in hepatocellular carcinoma, renal carcinoma, cervical cancer and colorectal cancer (9) (10) (11) . As for gastric cancers, little evidence is available concerning the role of mitophagy in gastric cancer progression involving cellular migration and survival. Therefore, it is necessary to establish the regulatory role of mitophagy in the biological function of gastric cancers.
Ample evidence has focused on the anti-apoptotic effect of mitophagy on cancer survival. However, there is little research evidence to suggest whether mitophagy has the ability to manipulate cancer migration. Cellular migration involves drastic structural changes, a process that demands high levels of energy and fully functional mitochondria whose quality and quantity are balanced by mitophagy (12) . Moreover, several studies have proposed the direct regulatory effect of mitophagy on cellular migration via stress fibers such as F-actin and tubulin (13) . Moreover, excessive reactive oxygen species (ROS) or oxidative stress have been found to influence F-actin homeostasis in cancers (14) . This information indicates the possible relationship between mitophagy and F-actin-based migration.
Yap regulates gastric cancer survival and migration via SIRT1/Mfn2/mitophagy
Several factors have been found to be related to activation of mitophagy. In response to hypoxic stress, FuNDC1 is dephosphorylated and mediates mitophagy activation, which provides a survival advantage for cardiomyocytes (15) . Moreover, under high glucose attack, Bnip3 is activated and offers beneficial actions on β-cells (16) . Recently, mitofusin 2 (Mfn2) is a novel controller for mitophagy activation (17) . In damaged mitochondria with lower mitochondrial membrane potential, Mfn2 is phosphorylated at Thr-111 and Ser-442 and selectively activates mitophagy (18) , resulting in the removal of bad mitochondria by lysosomes. This process could be enhanced by JnK pathways (19) . In contrast, loss of Mfn2 is associated with enhanced mitochondrial dysfunction. For example, Mfn2 deficiency in the heart leads to cardiomyopathy (20) . The age-induced reduction in Mfn2 levels is involved in musculoskeletal disorders (17) . However, whether Mfn2 is involved in gastric cancer cell survival and migration remains unknown.
Yes-associated protein (Yap) is overexpressed and has an oncogenic role in several types of tumors including gastric cancer (21) . Yap inhibition by siRnA inhibits gastric carcinoma growth and tumor metastasis, suggesting the vital role of Yap in cancer cell migration and survival (22) . Moreover, recent studies have indicated that the Hippo pathway controls the mitochondrial function via Bcl-xL (23) , demonstrating the possible relationship between Yap and mitochondria. Whether mitophagy is signaled by Yap and contributes to cancer progression is incompletely understood. In the present study, we explored the role of Yap in gastric cancer migration and survival, particularly focusing on Mfn2-mediated mitophagy. Cell culture. The human normal gastric mucosal cell line GES-1 and human gastric cancer cell line AGS were all purchased from the American Type Culture Collection (ATCC) (Manassas, VA, uSA) (24) . next, the cell lines were incubated in the Roswell Park Memorial Institute (RPMI)-1640 medium containing 10% fetal bovine serum (FBS) in an incubator with 5% CO 2 at 37˚C.
Materials and methods

Ethics
ROS detection and NAO staining.
To detect cellular ROS production, DCFH-DA (Beyotime Institute of Biotechnology, Jiangsu, China) was used. In brief, cells were incubated in FBS-free DMeM containing DCFH-DA (10 µM) for 30 min (25) . Then, the cells were washed with PBS. Flow cytometric analyses were performed using a BD FACSCalibur™ flow cytometer (BD Biosciences, San Jose, CA, uSA).
To measure the oxidation of cardiolipin, 10-N-nonyl acridine orange (nAO; 2 mmol/l; Molecular Probes, eugene, OR, uSA) was used. In normal cells, nAO interacts with non-oxidized cardiolipin and produces a characteristic green fluorescence (26) . However, after cardiolipin is oxidized, nAO cannot bind to it. We evaluate the fluorescence intensity to reflect the cardiolipin oxidation. Image-Pro Plus 6.0; Media Cybernetics, Rockville, MD, uSA) was used to obtain the mean densities of the region of interest (27) , which was normalized to that of the control group.
Transwell assay. Cells in all groups were digested and added into a 24-well Transwell plate where the chambers were then transferred in a manner that may avoid the formation of bubbles. A total of 0.5 ml cell suspension was added into the chambers and they were then incubated in an incubator for 24 h (28) . Subsequently, the extra liquids in the upper and lower chambers were discarded and cells in the upper chamber above the Transwell membrane was carefully wiped off using a cotton swab. Cells transferred in the lower chambers were fixed using pre-cooled formalin for 30 min, stained using 1% crystal violet for 10 min and washed in running water until they were totally clean (29) . Cells were dried naturally and observed under the microscope. Images were captured and observation results were recorded.
Scratch assay. When cell attachment was observed at the plate bottom, a sterile spearhead was used to slightly draw a line in the well, ensuring that the widths of all scratches were the same. Images were captured and the cover of 6-well plate was marked properly to guarantee the same observation field (30) . After 24 h, an Olympus inverted microscope was employed for observation of 6 fixed fields of vision.
Immunofluorescence. The cells were washed in PBS and permeabilized for 10 min at 4˚C in a solution of 0.1% Triton X-100 and 0.1% sodium citrate in PBS. Cells were washed 3 times in PBS and incubated overnight at 4˚C with the primary antibody (30) . The primary antibodies used in the present study were as follows: Tomm20 (1:1,000, #ab78547), LAMP1 (1:1,000, #ab24170), F-actin (1:1,000, #ab205) and cyt-c (1:1,000, #ab133504) (all from Abcam, Cambridge, MA, uSA), Sirt1 (1:500, #2310), Mfn2 (1:1,000, #11925) (both from Cell Signaling Technology, Inc., Danvers, MA, uSA).
Immunoblotting. Immunoblotting was carried out as described previously (31, 32) . Briefly, the cells were washed with PBS and lysed in RIPA buffer containing 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 50 mM Tris-HCl (pH 8.0), 10 mg/ml pepstatin A, 10 mg/ml leupeptin and 1 mM phenylmethylsulfonyl fluoride (PMSF). After centrifugation for 10 min, supernatant with 20 mg protein for each sample was subjected to immunoblotting analysis (33) . Primary antibodies used for immunoblotting were as follows: pro-caspase-3 (1:1,000; #9662), cleaved caspase-3 (1:1,000; #9664; both from Cell Signaling Technology), Bad (1:2,000; #ab90435; Abcam), Bax (1:2,000; #5023; Cell Signaling Technology), caspase-9 (1:1,000; #ab32539), Bnip3 (1:1,000; #ab109362; both from Abcam), LC3II (1:1,000; #3868; Cell Signaling Technology), p62 (1:1,000; #ab56416; Abcam), Beclin1 (1:1,000; #3495), Atg5 (1:1,000; #12994), Sirt1 (1:1,000; #2310), Mfn2 (1:1,000; #11925), FAK (1:1,000; #3285), integrin β1 (1:1,000; #34971), Talin-1 (1:1,000; #4021) (all from Cell Signaling Technology).
RNA isolation and quantitative RT-PCR (qPCR).
Total RNA was isolated from cells using TRIzol reagent (Invitrogen, Carlsbad, CA, uSA). RnA (1 µg) from each sample was reversely transcribed into cDNA using a Reverse Transcription kit (eurogentec, Fremont, CA, uSA). qPCR was performed with primers and matched probes from the universal Fluorescencelabeled Probe Library (Roche, Basel, Switzerland) (34) . The primers used in the present study were as follows: FAK forward primer, 5'-GAC TGG CCC AGT GTT CTT CGC TTC and reverse primer, 5'-GCT TCT GAC AGA AGG AAA GCC AAC; integrin β1 forward primer, 5'-TCA AAC AAC TTC ATG GTC CCA GTG CTC and reverse primer, 5'-TAA ACC TGA CTG GTT CGG GGG ATT TCT; Talin-1 forward primer, 5'-CGA CAT GAC CAA GTG GGA GCA GAA GTA and reverse primer, 5'-TGG AGC ACC TTT AAC CTG CTT TCC ATC.
JC-1 staining and ATP detection.
The mitochondrial potential was assessed using the probe JC-1, a sensitive fluorescent dye used to detect changes in mitochondrial potential (35) . Briefly, after treatment, cells were incubated with 10 mg/ml JC-1 for 10 min at 37˚C in the dark and monitored with a fluorescence microscope. Red-orange fluorescence was attributable to a potential-dependent aggregation in the mitochondria. Green fluorescence, reflecting the monomeric form of JC-1, appeared in the cytosol after mitochondrial membrane depolarization.
The level of ATP in cells was determined using the ATP Bioluminescence Assay kit. Briefly, harvested cultured cells were lysed with a lysis buffer, followed by centrifugation for 2 min at 4˚C. Finally, the level of ATP was determined by mixing 50 µl of the supernatant with 50 µl of luciferase reagent (36) , which catalyzed the light production from ATP and luciferin. The emitted light was linearly related to the ATP concentration and measured using a microplate luminometer.
MTT and TUNEL assay. MTT experiments were performed in 96-well plates. The cells were applied to the scaffold at a density of 10 4 cells/well. After 2 or 3 days of culture, the samples were washed 3 times with PBS, and then 50 µl of MTT was added to each well (37) . The samples were then incubated for 4 h in a humid atmosphere. The MTT solution was removed and 200 µl DMSO was added to each sample and incubated for 10 min. After the addition of Sorensen's buffer, the absorbance was determined at a wavelength of 570 nm.
A TuNEL assay to detect DNA fragmentation in cell nuclei (a marker for apoptosis in testicular tissue), was performed using an In Situ Cell Death Detection kit (Roche, Mannheim, Germany), according to the manufacturer's protocol. DAPI was used to label the nuclei. The results are expressed as apoptotic cells/tubule cross-section (38) .
Small RNA interference assay. To evaluate the functional role of Yap, siRNA was used to reduce its expression. For Yap, the sense strand siRNA, 5'-GCG ACA TTC AGG GuG ACu Auu-3' and antisense strand siRNA, 3'-TCG CuG uuC CTC CCA CuG AuA Au-5' were used (39) . Briefly, cultured cells were washed with Opti-Minimal Essential Medium without serum or antibiotics and seeded in 6-well plates to 30-40% confluence. The transfection reagent and siRnA were diluted separately in serum-free media, mixed and incubated for 10 min at room temperature to form the siRNA/lipid complex. This complex was then added to each well at a final concentration of 70 nM/well of siRnA. At 48 h after transfection, cells were collected to determine Yap protein expression levels by western blot analysis (40) .
Statistical analysis. Data analysis was conducted using SPSS 19.0 statistical software (SPSS, Inc., Chicago, IL, uSA). Measurement data are presented as mean ± standard deviation (SD). The one-way analysis of variance (AnOVA) was conducted to analyze comparisons among multi-groups. P<0.05 was assigned as indicative of statistical significance.
Results
Yap is upregulated in gastric cancer and activates mitophagy.
To determine the expression of Yap in gastric cancer in the present study, we carried out qRT-PCR and western blot analysis in normal gastric mucosal cell line GES-1 and gastric cancer cell line AGS. We found abundant Yap expression in AGS but not in the normal gastric mucosal cells (Fig. 1A and B) , suggesting that Yap may be involved in the development of gastric cancer. To explain the role of Yap in gastric cancer, we stably knocked down Yap expression using the siRNA technique in AGS cells. The knockdown efficiency was confirmed by western blotting (Fig. 1A and B) . Since mitophagy is vital for cancer biological function, we observed the change in mitophagy under Yap deficiency. Loss of Yap reduced mitophagy as evidenced by a lower content of mito-LC3II, p62, Beclin1 and Atg5 (Fig. 1C-G) . These data indicated that Yap sustained mitophagy activity. To further provide more evidence for the role of Yap in mitophagy, we conducted the co-staining of mitochondria and lysosomes. As shown in Fig. 1H , loss of Yap reduced the overlap of mitochondria and lysosomes. However, there was no change concerning the mitochondria and lysosomes in the siRNA-control group. Altogether, these data confirmed that Yap is a vital signal for mitophagy activation.
Next, we used MTT, caspase-3 activity and wound healing assay to examine the influence of mitophagy on gastric cancer viability and migration. Meanwhile, FCCP, an activator of mitophagy, was used as the gain-of-function assay in Yap-deleted AGS cells. Compared to the control group, loss of Yap reduced cellular viability as revealed by a lower OD value and increased caspase-3 activity (Fig. 1I and J) . However, re-activation of mitophagy by FCCP under Yap deficiency reversed cellular viability (Fig. 1I and J) . Similarly, results from the wound healing assay also uncovered that Yap promoted cancer mobilization (Fig. 1K and L) . Loss of Yap reduced the distance of cancer mobilization and this tendency was reversed by FCCP ( Fig. 1K and L) . Collectively, these data indicated that Yap maintained gastric cancer viability and mobilization via mitophagy.
Mitophagy inhibits gastric cancer death via blocking the caspase-9-related apoptosis pathway. To further investigate the mechanism by which mitophagy sustains cellular viability, we firstly detected the cellular apoptotic rate under Yap deficiency. Loss of Yap increased the number of TuNEL-positive cells ( Fig. 2A and B) . However, this harmful effect of Yap deficiency was reversed by re-activation of mitophagy. These data indicated that Yap preserved gastric cancer cell viability via blocking cellular apoptosis.
Since mitophagy is a self-clearing system for mitochondria; therefore, we proposed that Yap-regulated mitophagy has the ability to reduce the caspase-9-related mitochondrial apoptosis pathway. Firstly, we measured the change in proteins related to the caspase-9 apoptosis pathway. Loss of Yap increased caspase-3 and -9 and Bax expression but reduced c-IAP1 content (Fig. 2C-G) . These data indicated that Yap deletion initiated caspase-9-related cellular apoptosis. However, upon reactivation of mitophagy by FCCP, the apoptotic markers were abated (Fig. 2C-G) .
Apart from the downstream protein alteration, we also observed that Yap loss aggravated cytochrome c (cyt-c) leakage from mitochondria via immunofluorescence (Fig. 2H) . However, this trend was reversed by mitophagy activation by FCCP (Fig. 2H) . The cyt-c release was derived from mitochondrial oxidative stress. In healthy cells, mitochondrial cardiolipin retains cyt-c in the inner membrane of mitochondria. However, upon oxidation, cardiolipin may liberate cyt-c contributing to cyt-c leakage into the cytoplasm via mPTP. Therefore, we used NAO to observe cardiolipin oxidation. As shown in Fig. 2I and J, loss of Yap increased the expression of oxidized cardiolipin (CL). However, activation of mitophagy may reduce cardiolipin oxidation. Since cardiolipin oxidation is derived from excessive ROS, we aimed to ascertain whether Yap-regulated mitophagy had the ability to alleviate cellular oxidative stress. As shown in Fig. 2K and L, Yap deletion caused ROS overproduction via flow cytometric analysis. upon re-activation of mitophagy in Yap-deleted gastric cells by FCCP, the ROS content was reduced. Notably, we used the exogenous H 2 O 2 to mimic the ROS outburst in the control gastric cancer cells, which was used as the positive control group. Meanwhile, NAC, a ROS scavenger, was used to remove the oxidative stress in Yap-deleted cells, which was used as the negative control group. Exogenous H 2 O 2 not only increased the cellular ROS content (Fig. 2L ) but also induced cardiolipin (Fig. 2J ). However, nAC had the ability to reduce oxidative stress (Fig. 2L ) and (Fig. 2J ) in Yap-deleted cells. Altogether, these data indicated that Yap was the housekeeper for gastric cancer cell survival via activation of mitophagy which blocked the caspase-9-related apoptotic pathways.
Mitophagy handles F-actin-based cellular migration via reducing oxidative stress.
Apart from cellular apoptosis, cellular migration is another factor for the development of gastric cancer. Since cancer migration is related to the F-actinmediated cytoskeletal rearrangement, F-actin may contribute to the formation of lamellipodia which directs the cancer cells to move in some direction. In the present study, we used the cell membrane dye DiO to observe the change in lamellipodium. We found that loss of Yap impaired the formation of lamellipodia (Fig. 3A and B) . The shorter and less lamellipodium appeared in response to the Yap loss ( Fig. 3A and B) , which was accompanied by a lower number of migrated cells via Transwell assay (Fig. 3C and D) . However, activation of mitophagy reversed the formation of lamellipodium and therefore facilitated cellular migration. These data indicated that Yap regulated lamellipodium-based migration via mitophagy.
The lamellipodium consists of F-actin, a kind of stress fiber (41) . We found that Yap loss caused F-actin downregulation via immunofluorescence assay (Fig. 3e and F) . However, activation of mitophagy reversed the F-actin expression despite deletion of Yap. To ascertain the underlying mechanism underlying F-actin collapse under Yap inhibition, we focused on the ROS-induced oxidative stress. Previous research suggests that F-actin is regulated by oxidative stress and excessive ROS may impair F-actin synthesis (42) . In the present study, we found that exogenous H 2 O 2 treatment reduced the F-actin immunofluorescence intensity which was similar to the results noted in the Yap-deleted cells (Fig. 3e and F) . However, removal of ROS via NAC in Yap-deleted cells, restored the F-actin content, comparable to the effect of mitophagy reactivation in Yap-deleted cells.
Apart from cytoskeletal rearrangement, adhesive proteins are also implicated in cellular migration (43) . The expression of the adhesive markers FAK, integrin β1 and Talin-1 were analyzed using qPCR (Fig. 3G-I ) and western blot analyses (Fig. 3J-M) . The results revealed that Yap inhibition reduced FAK, Integrin β1 and Talin-1 expression at the mRNA and protein levels. In contrast, mitophagy activation by FCCP exerted opposite effects in relation to Yap deletion. Altogether, these results indicatedan important role of Yap in modulating gastric cancer migration via mitophagy.
Yap modulates mitophagy via the SIRT1/Mfn2 pathway. To ascertain the mechanism by which Yap sustains mitophagy activity, we focused on Mfn2 expression which is a novel receptor of mitophagy (44) . We demonstrated that loss of Yap expression reduced Mfn2 expression when compared to the control group (Fig. 4A and C) . Furthermore, several studies have suggested that Sirtuin 1 (SIRT1) is the upstream inducer of Mfn2 expression (45) , and therefore, we aimed to ascertain whether SIRT1 is involved in Mfn2 regulation by Yap. Firstly, we found that loss of Yap was associated with the downregulation of SIRT1 (Fig. 4A and B) . Furthermore, SIRT1 activator SRT1720 was used and it reversed SIRT1 expression albeit Yap deletion (Fig. 4A and B) . Moreover, application of SRT1720 further restored siRNA-Yap-reduced Mfn2 expression (Fig. 4A-C) . These data established the regulatory role of SIRT1 in Mfn2 expression. To provide further evidence for the role of SIRT1 in Mfn2 expression, we co-stained for SIRT1 and Mfn2. As shown in Fig. 4D , compared to the control group, loss of Yap reduced the SIRT1 and Mfn2 expression. However, SIRT1 activator SRT1720 reversed the SIRT1 expression and subsequent upregulated the Mfn2 content. Next, to demonstrate whether the SIRT/Mfn2 pathway was responsible for mitophagy activation, we examined the proteins involved in mitophagy. As shown in Fig. 4A and e-G, compared to the Yap-silenced group, reactivation of SIRT1 reversed the mitophagy activity as evidenced by increased mito-LC3II, Atg5 and p62. Altogether, these findings demonstrated that Yap signaled mitophagy via the SIRT1/Mfn2 pathway.
SIRT1/Mfn2 pathway is also involved in mitochondrial protection. Finally, to ascertain whether SIRT1 and Mfn2 are involved in gastric cancer viability, we observed mitochondrial function under SIRT1 activation. Firstly, mitochondria are the center for cellular energy metabolism. However, loss of Yap reduced ATP production (Fig. 5A ). This harmful effect was reversed by SIRT1 reactivation. Since the mitochondrial membrane potential is the source of ATP production (33), we consequently assessed the change in mitochondrial potential. Compared to the control group, loss of Yap reduced the membrane potential, which was restored via SIRT1 activator (Fig. 5B and D) . Furthermore, loss of Yap is associated with increased mPTP opening rate. In contrast, reactivation of SIRT1 suppressed the extensive mPTP opening (Fig. 5C ). The mPTP opening provides a channel for proton leakage into the cytoplasm, finally leading to membrane potential collapse.
Apart from energy production, mitochondria also produce excessive ROS to induce cellular apoptosis (46) . In the present study, we found that cellular anti-oxidant factors such as GSH and SOD were downregulated in response to the loss of Yap (Fig. 5e and G) . In contrast, MDA, an end product of lipid peroxidation, was upregulated (Fig. 5F ), indicative of cellular oxidative stress. However, recovery of SIRT1 exerted an opposite effect and reduced the levels of these markers of cellular oxidative stress (Fig. 5e-G) . Furthermore, we also assessed caspase-3 activity to ascertain whether SIRT1/Mfn2 is involved in cellular damage. Restoration of SIRT1 via its activator reduced the caspase-3 activity when compared to the Yap deficiency group (Fig. 5H) . Collectively, these data indicate that the SIRT1/Mfn2 pathway regulated by Yap is vital for mitochondrial function and cellular viability.
Discussion
Gastric cancer is a multifactorial process, and many molecular alterations have been shown to influence tumor initiation and development through abnormal gene expression or protein alterations (1) . Gastric cancer is the fifth leading cause of cancer-related death in both males and females worldwide and accounts for 8.8% of all such deaths (33) . Over the past several decades, studies concerning gastric cancer have provided knowledge about the genetic, epigenetic, transcriptome and metabolic alterations underlying this disease. Although the exact cause of gastric cancer is unclear, its pathogenesis is the same as that of other malignant tumors. It is a multi-step, multifactorial comprehensive disease. Gastric cancer cases can be divided into early-and advanced-stage gastric cancer. In recent years, the 5-year mortality rate has significantly decreased for early gastric cancer patients given the development of enteroscopy and surgical techniques. However, for advanced gastric cancer, the 5-year mortality remains 30-50% (3). early-stage gastric cancers are limited to the mucosa or submucosa, regardless of the size of the lesion and the presence of lymph node metastasis. Cancer that extends beyond the submucosa to invade the gastric muscular layer is middle-stage gastric cancers (47) , whereas tumors that infiltrate into or beyond the subserosa to nearby organs or metastasize are advanced-stage gastric cancers. In brief, advanced-stage gastric cancer patients have a reduced survival rate and the tumors exhibit a more aggressive or invasive property. Since the stage of the tumor determines treatment effectiveness and treatment strategy, it is worthwhile to explore the mechanism of gastric cancer progression such as survival, migration, invasion and apoptosis.
In the present study, we identified that Yap is a necessary factor for maintaining gastric cancer migration and viability. Yes-associated protein (Yap) is a 65 kDa proline-rich phosphoprotein, which is located at locus 11q22 (48) . A previous study reported that YAP may have oncogenic functions, and elevated YAP expression is associated with malignant tumors (21, 49) . In the present study, we found that Yap expression is increased in gastric cancer when compared to that noted in normal gastric mucosal cells. Moreover, Yap expression was associated with gastric cancer cell viability and migration, suggesting the tumor-promotive effect of Yap. To the best of our knowledge, this is the first study to describe the role of Yap in gastric cancer migration and survival, which supports the mechanism involved in the tumor development and progression by Yap. More importantly, our data offer a potential therapeutic target to intervene against gastric cancer involving cancer cell survival and migration. However, more clinical data are needed to support our theory.
We determined that Yap promoted cancer cell survival and mobilization via mitophagy. Loss of Yap abated the level of mitophagy, leading to the activation of the caspase-9-related apoptotic pathways (50) . Moreover, mitophagy inactivation was also related to excessive oxidative stress which caused F-actin degradation and lamellipodium collapse, finally leading to impairment in cancer cell motility. Although the majority of studies have uncovered the anti-apoptotic action of mitophagy on cell fate regardless of cancer cells or normal cells (51, 52) , little attention has focused on the relationship between cellular migration and mitophagy. We demonstrated that mitophagy contributed to the cellular migration by reducing ROS. Previous studies have found that oxidative injury may induce F-actin degradation and collapse, which eventually blunts Figure 6 . Yap sustains gastric cancer migration and viability via mitophagy. Yap activates SIRT1 which enhances the mitophagy receptor Mfn2 expression, strongly maintaining mitophagy activity. Mitophagy blocks the caspase-9 apoptotic pathway, abates cellular oxidative and prevents mitochondrial function. These protective effects of Yap/SIRT1/Mfn2 contribute to cell survival and migration. Yap, Yes-associated protein; Mfn2, mitofusin 2; SIRT1, Sirtuin 1 the formation of lamellipodium. These findings were similar to our results. Based on this, we confirmed the core role of mitophagy in cellular migration (53) . notably, we also found that mitophagy had the ability to increase ATP production. Considering that the cellular migration is dependent on energy production, the ATP-promotive effect of mitophagy could be another factor to enhance cellular migration.
We found that Yap was the upstream controller of mitophagy, which elucidated the regulatory machinery of mitophagy. Mechanistically, Yap preserved Mfn2 expression which enhanced mitophagy activity. Furthermore, SIRT1 was signaled by Yap and sustained Mfn2-required mitophagy. These data hint at the possible links between Yap and mitochondria. Recent research has found that Yap preserves mitochondrial function via regulation of JnK pathways (54) . In the present study, we confirmed that the protective effect of Yap on mitochondria was attributed to mitophagy activation. Accordingly, our findings provide more information to the role of Yap in tumorigenesis involving mitochondrial homeostasis.
Collectively, the results of our study illustrate the important role of Yap in gastric cancer migration and survival (Fig. 6) . Yap signals Sirt1 which activates Mfn2-mediated mitophagy, contributing to mitochondrial homeostasis. The Yap/SIRT1/ Mfn2/mitophagy pathways block the caspase-9-related apoptotic axis and enhance F-actin-based cellular migration, responsible for gastric cancer cell migration and survival. These data identify Yap/SIRT1/Mfn2/mitophagy pathways as a potential target for the treatment of gastric cancer, and highlight a new strategy for treating gastric cancer involving Yap protein and Mfn2-mediated mitophagy.
